Status:
ACTIVE_NOT_RECRUITING
A Trial of Diabetes-educated Psychologist to Improve HbA1c and Reduce Diabetes-related Distress
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Type1diabetes
Psychology Functional Behavior
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Type 1 diabetes is associated with a significant increase in mortality, cardiovascular disease, injuries on eyes and kidneys. These risks are largely dependent on glycemic control. Multiple strategies...
Eligibility Criteria
Inclusion
- Informed consent obtained before trial-related activities (i.e., any activity that would not have been performed during routine patient management)
- Clinical diagnosis of Type 1 diabetes
- Adult patients over 18 years of age
- HbA1c \> 62 mmol/mol
Exclusion
- Type 2 diabetes
- Diabetes duration \<1 year
- Long-term Systemic glucocorticoid treatment during the last 3 months
- Changed treatment the last 3 months regarding MDI vs. Insulin pump or added or stopped CGM or FGM therapy
- Current or planned pregnancy or breastfeeding during the next 12 months
- Planned move during the next 12 months making it not possible to participate in study activities
- Other reason determined by the investigator not being appropriate for participation
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT03753997
Start Date
January 1 2019
End Date
December 31 2026
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NU Hospital Group
Uddevalla, Sweden, 45180